An off-the-shelf solution with a single-stage procedure for knee cartilage and osteochondral defect repair,1 comprised of a proprietary implant biomaterial that is porous, biocompatible and biodegradable.2,3
Derived from a naturally occurring calcium carbonate known as aragonite, the CARTIHEAL AGILI-C Implant is a porous, biodegradable2,3 and biphasic biomaterial scaffold for cartilage regeneration.
Shown to deliver clinically meaningful improvements in pain, function and quality of life,1 the CARTIHEAL AGILI-C Implant is the only device approved for the treatment of knee cartilage and osteochondral defects in patients with or without mild to moderate osteoarthritis (KL 0-3).4
Effective: Twice the pain reduction*4
Versatile: Treat small and large lesions, with or without the presence of osteoarthritis (OA)1
Convenient: Implanted using a single, simple surgical procedure, with no need for donor matching or cell harvesting
*Compared to the surgical standard (microfracture or debridement).
**Illustration only; not an actual representation.
Products may not be available in all markets because product availability is subject to the regulatory and/or medical practices in individual markets. Please contact your Smith+Nephew representative or distributor if you have questions about the availability of Smith+Nephew products in your area.
To order the instruments used in this technique, call +1 800 343 5717 in the U.S. or contact an authorized Smith+Nephew representative. Prior to performing this technique, consult the Instructions for Use documentation provided with individual components – including indications, contraindications, warnings, cautions and instructions. Individual patient responses may vary.
Caution: U.S. Federal law restricts this device to sale by or on the order of a physician.
1.CartiHeal 2009. Indications for Use: Agili-C™ implant.
2. Kon E, et al. J Orthop Surg Res. 2015 May 28;10:81.
3. Kon E, et al. Knee Surg Sports Traumatol Arthrosc. 2014 Jun;22(6):1452-64.
4. Altschuler, et al. AJSM 2023: 51(4), 957-967.
5. Kon E, et al. Am J Sports Med. 2021 Mar;49(3):588-598
Text